| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 160.612 | 139.446 | 118.912 | 130.976 | 72.334 | 48.932 | 46.422 | 0 | 0 | 0 |
| Total Income - EUR | 161.852 | 156.125 | 119.620 | 130.976 | 72.337 | 53.671 | 47.289 | 20 | 0 | 0 |
| Total Expenses - EUR | 168.930 | 154.133 | 108.408 | 129.518 | 92.392 | 64.937 | 59.052 | 417 | 254 | 253 |
| Gross Profit/Loss - EUR | -7.078 | 1.992 | 11.212 | 1.458 | -20.055 | -11.266 | -11.763 | -397 | -254 | -253 |
| Net Profit/Loss - EUR | -7.078 | 1.247 | 8.862 | 148 | -20.778 | -11.761 | -12.555 | -397 | -254 | -253 |
| Employees | 5 | 6 | 5 | 5 | 4 | 2 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Livia Pharmexim Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 18.438 | 18.775 | 22.753 | 29.759 | 30.015 | 31.883 | 31.574 | 31.314 | 30.965 | 30.792 |
| Current Assets | 83.529 | 97.679 | 148.407 | 144.139 | 109.829 | 105.869 | 56.991 | 49.887 | 49.736 | 49.458 |
| Inventories | 37.898 | 41.976 | 95.709 | 91.391 | 67.251 | 59.111 | 47.474 | 47.804 | 47.659 | 47.392 |
| Receivables | 43.463 | 63.006 | 48.584 | 52.400 | 42.291 | 44.680 | 8.371 | 2.083 | 2.077 | 2.065 |
| Cash | 2.168 | -7.302 | 4.114 | 348 | 287 | 2.077 | 1.145 | 0 | 0 | 0 |
| Shareholders Funds | -863 | 393 | -6.416 | 36.828 | 15.343 | 3.291 | -9.337 | -9.763 | -9.987 | -9.931 |
| Social Capital | 45 | 45 | 44 | 43.021 | 42.195 | 41.395 | 40.477 | 40.602 | 40.479 | 40.253 |
| Debts | 102.830 | 116.061 | 177.576 | 137.104 | 124.550 | 134.509 | 97.901 | 90.964 | 90.688 | 90.181 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Livia Pharmexim Srl